¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2018 ¼­¿ï´ëÇб³¾î¸°À̺´¿ø ¼Ò¾Æû¼Ò³â¾Ï¼¾ÅÍ ½ÉÆ÷Áö¾ö : 2018-09-08

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2018 ¼­¿ï´ëÇб³¾î¸°À̺´¿ø ¼Ò¾Æû¼Ò³â¾Ï¼¾ÅÍ ½ÉÆ÷Áö¾ö : 2018-09-08
±³À°ÀÏÀÚ : 2018-09-08
±³À°Àå¼Ò : ¼­¿ï´ëÇб³º´¿ø ÀÓ»ó Á¦2°­ÀǽǠ 
±³À°ÁÖÁ¦ : 2018 ¼­¿ï´ëÇб³¾î¸°À̺´¿ø ¼Ò¾Æû¼Ò³â¾Ï¼¾ÅÍ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ¼­¿ï´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¼Ò¾Æû¼Ò³â°ú  
´ã´çÀÚ : °­ÇüÁø
¿¬¶ôó : 02-2072-3304  
À̸ÞÀÏ : kanghj@snu.ac.kr      
±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 08ÀÏ ÀÓ»ó Á¦2°­ÀǽǠ10:30~11:00 MSC based pediatric brain tumor treatment  ±è½Â±â(¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 09¿ù 08ÀÏ ÀÓ»ó Á¦2°­ÀǽǠ11:00~11:30 NGS based targeted pediatric cancer treatment  ÀÌÁö¿ø(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 09¿ù 08ÀÏ ÀÓ»ó Á¦2°­ÀǽǠ11:30~12:00 Precision medicine based on pharmacogenomics  ±èÇý¸®(¼­¿ï¾Æ»êº´¿ø) 
½Ä»ç 09¿ù 08ÀÏ ÀÓ»ó Á¦2°­ÀǽǠ12:00~13:00 ½Ä»ç  () 
±³À°½Ã°£ 09¿ù 08ÀÏ ÀÓ»ó Á¦2°­ÀǽǠ13:00~13:40 Prof of Pediatric Oncology and senior PI Early Drug Development  Christian Michel Zwaan(Principal Investigator Head Trial and Data Centrum, Prinses Maxima Centrum for Pediatric Oncology, Netherland) 
±³À°½Ã°£ 09¿ù 08ÀÏ ÀÓ»ó Á¦2°­ÀǽǠ13:40~14:20 Antigen specific T cell therapies for pediatric malignancies  Catherine Bollard(Dep. of Pediatrics, Children¡¯s National Medical Center, USA) 
±³À°½Ã°£ 09¿ù 08ÀÏ ÀÓ»ó Á¦2°­ÀǽǠ14:20~14:40 Development of Haploidentical HSCT based on pharmacokinetic modeling  È«°æÅÃ(¼­¿ï´ëÇб³º´¿ø) 
È޽Ġ09¿ù 08ÀÏ ÀÓ»ó Á¦2°­ÀǽǠ14:40~14:50 È޽Ġ () 
±³À°½Ã°£ 09¿ù 08ÀÏ ÀÓ»ó Á¦2°­ÀǽǠ14:50~15:10 Imaging study for pediatric cancer  ÃÖ¿µÈÆ(¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 09¿ù 08ÀÏ ÀÓ»ó Á¦2°­ÀǽǠ15:10~15:30 Nuclear medicine study for pediatric cancer  Ãµ±âÁ¤(¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 09¿ù 08ÀÏ ÀÓ»ó Á¦2°­ÀǽǠ15:30~15:50 Surgical study for pediatric cancer  ±èÇö¿µ(¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 09¿ù 08ÀÏ ÀÓ»ó Á¦2°­ÀǽǠ15:50~16:10 Radiotherapy study for pediatric cancer  ±èÁÖ¿µ(±¹¸³¾Ï¼¾ÅÍ) 
È޽Ġ09¿ù 08ÀÏ ÀÓ»ó Á¦2°­ÀǽǠ16:10~16:20 È޽Ġ () 
±³À°½Ã°£ 09¿ù 08ÀÏ ÀÓ»ó Á¦2°­ÀǽǠ16:20~17:00 History and the Current Status of the AML-BFM studies  Joerg Ritter(Dep. of Pediatric Hematology and Oncology, Munster University Hospital, Germany) 
±³À°½Ã°£ 09¿ù 08ÀÏ ÀÓ»ó Á¦2°­ÀǽǠ17:00~17:40 Current status of clinical study for pediatric cancer patients in Japan  Yoshiyuki Takahashi(Dep. Pediatrics, Nagoya University Graduate School of Medicine, Japan) 
Åä·Ð 09¿ù 08ÀÏ ÀÓ»ó Á¦2°­ÀǽǠ17:40~18:00 Future direction for pediatric cancer study in Korea  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2018 ¼­¿ï´ëÇб³¾î¸°À̺´¿ø ¼Ò¾Æû¼Ò³â¾Ï¼¾ÅÍ ½ÉÆ÷Áö¾ö : 2018-09-08""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÁÁÀº¹®È­º´¿ø ´ëÇѽŻý¾ÆÇÐȸ ºÎ»ê°æ³²Áöȸ Áý´ãȸ : 2018-09-10
´ÙÀ½±Û 2018 ´ëÇѽŰæÁ¾¾çÇÐȸ Ãß°èÇмú´ëȸ : 2018-09-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20898 °æ±â ¿ëÀμ¼ºê¶õ½ºº´¿ø µðÁöÅÐÀÇ·á½ÉÆ÷Áö¾ö -¹Ì·¡ ÀǷḦ À§ÇÑ ±³·ù¿Í Çù·Â : 2024-07-04 0 15 2024-05-28
20897 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day1) : 2024-07-04 0 10 2024-05-28
20896 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Àڱ󻸷Áõ½ÄÁõ) : 2024-07-02 0 14 2024-05-28
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 12 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 31 2024-05-28
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 121 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 42 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 120 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 34 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 23 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 19 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 44 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 13 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 21 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 12 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷